AnaptysBio, Inc. (ANAB) Analyst Forecast

$43.30

$0.46 (-1.05%)
Last update: 04:00 PM EST
Day's range
$42.63
Day's range
$45.32

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/10/2025 Wedbush David Nierengarten $50.00 $33.26   50.33%
11/10/2025 Truist Financial Joon Lee $36.00 $34.28   5.03%
10/15/2025 Wedbush David Nierengarten $70.00 $31.85   119.78%
05/06/2025 Guggenheim Yatin Suneja $54.00 $20.12   168.39%
02/03/2025 Wolfe Research Andy Chen $25.00 $16.66   50.06%
12/11/2024 H.C. Wainwright Emily Bodnar $19.00 $15.51   22.5%
11/06/2024 H.C. Wainwright Emily Bodnar $52.00 $19.38   168.32%
11/06/2024 Leerink Partners David Risinger $45.00 $19.38   132.2%
10/21/2024 Guggenheim Yatin Suneja $90.00 $34.98   157.29%
10/15/2024 Piper Sandler Yasmeen Rahimi $80.00 $34.74   130.28%
10/03/2024 New Street David Risinger $35.00 $35.22   -0.62%
08/15/2024 Truist Financial Joon Lee $30.00 $34.65   -13.42%
04/16/2024 Leerink Partners David Risinger $47.00 $21.27   120.97%

AnaptysBio, Inc. FAQ's

AnaptysBio, Inc. has been rated by research analysts at Barclays, Wedbush, Truist Financial, Stifel Nicolaus, H.C. Wainwright, Guggenheim in the past 90 days.